AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIO-TECHNE Corp Director's Dealing 2016

May 9, 2016

30718_dirs_2016-05-09_be0c06ba-d0f1-42c8-a07e-442d5f5f48de.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-05-05

Reporting Person: Dinarello Charles A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-05	Common Stock	M	5000.00	$56.17	Acquired	11559.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-05	Stock Options (Right to Buy)	$56.17	M	5000.00	Disposed	2016-10-25	Common Stock (5000.00)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$91.78	2024-10-29	Common Stock (4000.00)	4000.00	Direct
Stock Options (Right to Buy)	$91.78	2024-10-30	Common Stock (4000.00)	4000.00	Direct
Stock Options (Right to Buy)	$87.39	2023-10-30	Common Stock (4000.00)	4000.00	Direct
Stock Options (Right to Buy)	$87.34	2025-10-28	Common Stock (4260.00)	4260.00	Direct
Stock Options (Right to Buy)	$70.35	2021-10-26	Common Stock (5000.00)	5000.00	Direct
Stock Options (Right to Buy)	$66.90	2022-10-24	Common Stock (5000.00)	5000.00	Direct
Stock Options (Right to Buy)	$66.90	2022-10-24	CommonS tock (5000.00)	5000.00	Direct
Stock Options (Right to Buy)	$66.59	2017-10-24	Common Stock (5000.00)	5000.00	Direct
Stock Options (Right to Buy)	$65.47	2018-10-22	Common Stock (5000.00)	5000.00	Direct
Stock Options (Right to Buy)	$63.03	2019-10-28	Common Stock (5000.00)	5000.00	Direct
Stock Options (Right to Buy)	$61.46	2020-10-27	Common Stock (5000.00)	5000.00	Direct
Stock Options (Right to Buy)	$56.17	2016-10-25	Common Stock (5000.00)	5000.00	Direct